Document Detail


HIV seroprevalence among male IVDUs in Houston, Texas.
MedLine Citation:
PMID:  2135633     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
HIV seroprevalence was 8.4 percent in a sample of 921 heterosexual male intravenous drug users in Houston, Texas who were not in drug treatment at the time of the study. Males who were Black, injected drugs daily, or had a history of syphilis had greater odds of being HIV positive than participants without those characteristics.
Authors:
M L Williams
Related Documents :
12605563 - The role of pharmacological enhancement in protease inhibitor-based highly active antir...
11367453 - Fifth conference on retroviruses & opportunistic infections. interview by ron baker.
18549343 - Nov-002, a mimetic of glutathione disulfide.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  American journal of public health     Volume:  80     ISSN:  0090-0036     ISO Abbreviation:  Am J Public Health     Publication Date:  1990 Dec 
Date Detail:
Created Date:  1990-12-26     Completed Date:  1990-12-26     Revised Date:  2010-09-10    
Medline Journal Info:
Nlm Unique ID:  1254074     Medline TA:  Am J Public Health     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1507-9     Citation Subset:  AIM; IM; X    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
African Americans
HIV Seroprevalence*
Hispanic Americans
Humans
Male
Mexico / ethnology
Sexual Behavior
Substance Abuse, Intravenous / complications*,  ethnology
Syphilis / complications
Texas
Grant Support
ID/Acronym/Agency:
5 R 18 DA05156/DA/NIDA NIH HHS
Comments/Corrections
Comment In:
Am J Public Health. 1992 Jan;82(1):125   [PMID:  1580918 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Osteoarticular allografts for reconstruction in the proximal part of the humerus after excision of a...
Next Document:  Histological evaluation of biocompatible orthopaedic polymer.